These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10917789)

  • 41. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications.
    Friedman SR; Wainberg MA; Drucker E
    AIDS; 1998 Nov; 12(16):2089-93. PubMed ID: 9833849
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of Viroseq-HIV version 2 for HIV drug resistance.
    Mukaide M; Sugiura W; Matuda M; Usuku S; Noguchi Y; Suzuki K; Kawata K; Ito A; Sagara H; Yamada K; Kondo M; Imai M
    Jpn J Infect Dis; 2000 Oct; 53(5):203-5. PubMed ID: 11135705
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug-resistant HIV: predicting the future.
    Laurence J
    AIDS Read; 2001 Oct; 11(10):485-6. PubMed ID: 11708079
    [No Abstract]   [Full Text] [Related]  

  • 45. The K65R mutation: selection, frequency, and possible consequences.
    Moyle GJ
    AIDS Read; 2004 Nov; 14(11):595-7, 601-3. PubMed ID: 15570671
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug-resistant HIV infection among drug-naive patients in Israel.
    Grossman Z; Lorber M; Maayan S; Bar-Yacov N; Levy I; Averbuch D; Istomin V; Chowers M; Sthoeger Z; Ram D; Rudich H; Mileguir F; Pavel R; Almaliach R; Schlaeffer F; Kra-Oz Z; Mendelson E; Schapiro JM; Riesenberg K
    Clin Infect Dis; 2005 Jan; 40(2):294-302. PubMed ID: 15655750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine.
    Atkinson B; Isaacson J; Knowles M; Mazabel E; Patick AK
    J Infect Dis; 2000 Aug; 182(2):420-7. PubMed ID: 10915071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Consensus documents and clinical guidelines on resistance to antiretroviral agents].
    Antela A; Iribarren JA; Clotet B; Guerra L
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):47-52. PubMed ID: 11428061
    [No Abstract]   [Full Text] [Related]  

  • 49. Lack of emergence of genotypic resistance to stavudine after 2 years of monotherapy.
    Soriano V; Dietrich U; Villalba N; Immelmann A; Gil-Aguado A; Echevarría S; Clotet B; Ocaña I; Santamaría JM; Bouza E; Barona V; Gatell JM; González-Lahoz J
    AIDS; 1997 Apr; 11(5):696-7. PubMed ID: 9108961
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antiretroviral resistance testing. A necessary element in the follow-up of the HIV-infected patient].
    Alcamí J; Rubio R
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):1-2. PubMed ID: 11428052
    [No Abstract]   [Full Text] [Related]  

  • 51. More news from ICAAC.
    Clifton CE; Vázquez E
    Posit Aware; 2002; 13(2):17-8. PubMed ID: 12001922
    [No Abstract]   [Full Text] [Related]  

  • 52. Resistance testing debate: does it make the grade?
    Simmons P
    Res Initiat Treat Action; 1999 Oct; 5(4):9-12. PubMed ID: 11366943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
    de Mendoza C; Martín-Carbonero L; Gallego O; Corral A; González-Lahoz J; Soriano V
    J Med Virol; 2005 May; 76(1):1-6. PubMed ID: 15778973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ICAAC study on resistance.
    Burgess G
    Surviv News (Atlanta Ga); 2002 Feb; ():14. PubMed ID: 11870996
    [No Abstract]   [Full Text] [Related]  

  • 55. Viral patterns of unboosted 908 identified.
    AIDS Patient Care STDS; 2003 Aug; 17(8):431. PubMed ID: 13678545
    [No Abstract]   [Full Text] [Related]  

  • 56. HIV protease inhibitors.
    Winslow DL; Otto MJ
    AIDS; 1995; 9 Suppl A():S183-92. PubMed ID: 8819585
    [No Abstract]   [Full Text] [Related]  

  • 57. HIV resistance: a primer.
    PI Perspect; 1996 Nov; (No 20):6-7. PubMed ID: 11363971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance to antiretrovirals is a growing concern.
    Das P
    Lancet; 2003 Jul; 362(9380):300. PubMed ID: 12892983
    [No Abstract]   [Full Text] [Related]  

  • 59. [Human immunodeficiency virus resistance to antiretroviral drugs].
    Karmochkine M; Descamps D
    Ann Med Interne (Paris); 1999 Dec; 150(8):615-22. PubMed ID: 10686643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonadherence raises concerns over resistance.
    AIDS Alert; 1998 Sep; 13(9):108. PubMed ID: 11365793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.